Get the Stockscreener App
0.1665
1.90%
+0.0031
Acutus Medical Inc stock is currently priced at $0.1665, with a 24-hour trading volume of 247.70K.
It has seen a +1.90% increased in the last 24 hours and a -15.87% declined in the past month.
The chart indicates a potential bullish trend, as the stock is above the $0.1648 pivot point. If it approaches the $0.1685 resistance level, significant changes may occur.
Previous Close:
$0.1634
Open:
$0.1659
24h Volume:
247.70K
Market Cap:
$4.95M
Revenue:
$19.66M
Net Income/Loss:
$-32.79M
P/E Ratio:
-0.1103
EPS:
-1.51
Net Cash Flow:
$-60.99M
1W Performance:
-2.06%
1M Performance:
-15.87%
6M Performance:
-69.17%
1Y Performance:
-79.94%
1D Range:
$0.16
$0.169
52W Range:
$0.16
$1.0899
Acutus Medical Inc Stock (AFIB) Company Profile
Name
Acutus Medical Inc
Sector
Industry
Phone
442 232 6080
Address
2210 Faraday Avenue, Suite 100, Carlsbad
Acutus Medical Inc Stock (AFIB) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-15-21 | Downgrade | JP Morgan | Neutral → Underweight |
| Oct-22-21 | Initiated | Goldman | Neutral |
| Jul-15-21 | Upgrade | Canaccord Genuity | Hold → Buy |
| Mar-19-21 | Downgrade | JP Morgan | Overweight → Neutral |
| Mar-19-21 | Downgrade | William Blair | Outperform → Mkt Perform |
| Jan-14-21 | Downgrade | BofA Securities | Buy → Neutral |
| Aug-31-20 | Initiated | BTIG Research | Buy |
| Aug-31-20 | Initiated | BofA Securities | Buy |
| Aug-31-20 | Initiated | Canaccord Genuity | Hold |
| Aug-31-20 | Initiated | JP Morgan | Overweight |
| Aug-31-20 | Initiated | William Blair | Outperform |
View All
Acutus Medical Inc Stock (AFIB) Latest News
Acutus Medical Reports Fourth Quarter and Full Year 2023 Financial Results
GlobeNewswire Inc.
Why Peraso Shares Are Trading Lower By Over 23%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Benzinga
Why Fusion Pharmaceuticals Shares Are Trading Higher By Around 95%; Here Are 20 Stocks Moving Premarket
Benzinga
Why Humana Shares Are Trading Lower By Over 11%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Benzinga
Why IBM Shares Are Trading Higher By Over 7%; Here Are 20 Stocks Moving Premarket
Benzinga
Why Symbotic Shares Are Trading Higher By Around 22%; Here Are 20 Stocks Moving Premarket
Benzinga
Acutus Medical Inc Stock (AFIB) Financials Data
Acutus Medical Inc (AFIB) Revenue 2024
AFIB reported a revenue (TTM) of $19.66 million for the quarter ending September 30, 2023, a +24.72% rise year-over-year.
Acutus Medical Inc (AFIB) Net Income 2024
AFIB net income (TTM) was -$32.79 million for the quarter ending September 30, 2023, a +61.87% increase year-over-year.
Acutus Medical Inc (AFIB) Cash Flow 2024
AFIB recorded a free cash flow (TTM) of -$60.99 million for the quarter ending September 30, 2023, a +39.31% increase year-over-year.
Acutus Medical Inc (AFIB) Earnings per Share 2024
AFIB earnings per share (TTM) was -$1.24 for the quarter ending September 30, 2023, a +60.00% growth year-over-year.
About Acutus Medical Inc
Acutus Medical, Inc., an arrhythmia management company, designs, manufactures, and markets a range of tools for catheter-based ablation procedures to treat various arrhythmias in the United States and internationally. The company's product portfolio includes novel access sheaths, transseptal crossing tools, diagnostic and mapping catheters, conventional and contact force ablation catheters, and mapping and imaging consoles and accessories, as well as supporting algorithms and software programs. Acutus Medical, Inc. was incorporated in 2011 and is headquartered in Carlsbad, California.
1.69%
0.48%
Cap:
|
Volume (24h):